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Abstract
Objective: A short period of warm ischemia during lung allograft implantation is inevitable. We studied the effect of 2 h of
warm ischemia before implantation after 18 h of cold preservation on reperfusion edema and pulmonary hemodynamics in a large
animal model. Methods: Left lung transplantation was performed in ten weight-matched pigs (25–31 kg). Donor lungs were
flushed with 1.5 l cold (1°C) LPD solution and preserved for 20 h. In Group I (n5) the grafts were preserved for 20 h at 1°C
and topically cooled with ice slush during implantation until reperfusion. In Group II (n5) lungs were stored at 1°C for 18 h
followed by 2 h preservation at room temperature (20°C). Topical cooling was not used during implantation. At 1 h after
reperfusion the recipient contralateral right pulmonary artery and bronchus were ligated to assess graft function only.
Extravascular lung water index (EVLWI), intrathoracic blood volume (ITBV), mean pulmonary artery pressure (PAP) and cardiac
output (CO) were assessed during a 4 h observation period. Quantitative myeloperoxidase (MPO) activity and thiobarbituric
acid-reactive substance (TBARS) levels as an indicator for lipid peroxidation were determined in allograft tissue samples taken 5
h after reperfusion. Results: In Group II a tendency to improved pulmonary vascular resistance and cardiac output was noted.
Surprisingly, lung edema, assessed by EVLWI, did not increase in animals with warm ischemia. Even a tendency to a reduced
EVLWI was noted. However, differences between groups did not reach statistical significance. Gas exchange did not differ
statistically significant between groups. Conclusion: Our results indicate that a short period of warm ischemia before reperfusion
does not lead to increased pulmonary edema. In animals with a short period of warm ischemia before reperfusion, even a tendency
to reduced posttransplant lung reperfusion injury was noted. In this model, topical graft cooling during lung implantation did not
improve posttransplant graft function. © 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Observing the clinical practice of different lung trans-
plant groups, a great difference in the use of topical
cooling with ice slush during implantation was noted. In
experimental designs, even a cooling jacket [1] was used.
And indeed, the importance of rewarming of the organ
before reperfusion has not been studied extensively in the
field of lung transplantation.
Storage at low temperatures is of course the basic
measure in organ preservation. However, reperfusion of
the ice cold organ might have detrimental effects. A slow
rewarming phase during implantation which allows bet-
ter activation of protective endothelial mechanisms at the
time of reperfusion might be beneficial, as for example
synthesis of prostaglandins and nitric oxide production.
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In this study topical cooling during implantation was
compared to a slow rewarming phase before reperfu-
sion in a large animal model of reperfusion injury
following unilateral lung transplantation.
2. Materials and methods
2.1. Animals and operati6e procedure
Ten weight-matched pairs of outbred pigs served as
donors and recipients. Harvest and left lung transplan-
tation were performed as previously reported [2].
2.2. Donor procedure
Donor animals were intubated with an endotracheal
tube and anesthetized with halothane 1.5% (Synmedic,
Zu¨rich, Switzerland). Mechanical ventilation was estab-
lished with 100% oxygen at a tidal volume of 550 ml, a
rate of 20 breaths:min and 5 cm H2O of positive
end-expiratory pressure (PEEP). An FiO2 of 1.0 was
maintained throughout the whole procedure. After a
median sternotomy, the superior and inferior venae
cavae, the ascending aorta, the main pulmonary artery
(PA) and the trachea were isolated. Animals were hep-
arinized (400 U:kg), and a curved metal tipped cannula
was inserted through a purse string suture in the main
PA just distal to the valve. Before administration of the
flush solution, 250 mg prostaglandin E1 (PGE1)
(Prostin VR Pediatric; The Upjohn Company, Kalama-
zoo, MI) was injected directly into the main PA. Car-
diac inflow was occluded by ligation of the superior and
inferior venae cavae 20 s after the infusion of PGE1.
The inferior vena cava was cut proximal to the ligation
and the tip of the left atrium was excised for decom-
pression of the PA flush. The lungs were perfused
immediately, at a pressure of 40 cm H2O, with 1.5 l
LPD solution (Perfadex®, Upjohn:Medisan Pharma-
ceuticals AB, Uppsala, Sweden). During the flush the
lungs were cooled topically by flooding the chest with
cold (4°C) saline solution (0.9%). When the flushing
was completed, the trachea was clamped at mid-inspira-
tion and the heart–lung block was excised. The har-
vested organs were stored in LPD solution (1°C) for 20
h before implantation.
2.3. Recipient procedure
Recipient animals were placed in the right lateral
decubitus position after intubation with a single lumen
endotracheal tube and ventilated with FiO2 1.0 and
1.5% isoflurane (Abbott, Baar, Switzerland). The left
jugular vein and artery were exposed and cannulated
for the introduction of a Swan–Ganz catheter and the
thermistor-tipped fiberoptic catheter.
A left thoracotomy was performed in the fifth inter-
costal space. The hemiazygos vein was ligated and
divided, and a left pneumonectomy completed after
dissection of the hilum. The right PA, the pulmonary
arterial branch to the right upper lobe, and the right
intermediate bronchus were encircled with 1-0 silk liga-
tures or umbilical tape. This was in preparation to
exclude the right lung from perfusion and ventilation
following reperfusion to assess allograft function only.
The donor left lung was then isolated from the heart–
lung block.
With a partial occlusion clamp in place the left
atrium was opened between the superior and inferior
pulmonary vein and prepared for anastomosis. The left
atrial anastomosis was carried out with a running
monofilament suture (Prolene 5-0) using an everting
mattress technique. The pulmonary artery anastomosis
was completed with a monofilament suture (Prolene
5-0) using a continuous over-and-over technique. A
Fogarty venous embolectomy catheter was passed
across the field as a bronchial blocker after division of
the left mainstem bronchus. The bronchial anastomosis
was carried out with a running 4-0 monofilament suture
(Prolene) using simple non-telescoping technique. One
hour after reperfusion the right main PA, the arterial
branch to the upper lobe and the right intermediate
bronchus were ligated. The right upper lobe was ex-
cluded from ventilation by advancing the tracheal tube
to the carina. Subsequently, two chest tubes were in-
serted into the thoracic cavity and placed on suction.
The thoracotomy was closed with umbilical tape and
continuous sutures.
2.4. Study groups
In Group I (n5) donor lungs were harvested as
described above and preserved for 20 h at 1°C. During
separation and implantation the lungs were cooled top-
ically with ice slush. In Group II (n5) the lungs were
harvested in identical technique and preserved for 18 h
at 1°C. Following cold preservation, the lungs were
kept at room temperature (20oC) during separation of
the left lung. Topical cooling with ice slush was not
used and the lung graft was exposed to the body
temperature of the recipient during implantation.
All animals received humane care in compliance with
the European Convention on Animal Care. The proto-
col was approved by the local animals study committee.
2.5. Assessment
One hour after reperfusion of the transplanted lung,
the right pulmonary arteries and the right main
bronchus were ligated to assess allograft function only.
During the assessment period anesthesia was main-
tained with fluothane 1.5%. Systemic arterial, PA, cen-
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tral venous and left atrial pressure were recorded con-
tinuously. Arterial and mixed venous blood were col-
lected for gas analysis every 60 min.
At the end of the assessment period, 5 h after
reperfusion, the animals were sacrificed. Upper lobe
allograft samples were submitted to histologic exami-
nation and tissue MPO and TBARS assay.
2.6. Extra6ascular lung water
A fiberoptic catheter (System Cold Z-021, Pulsion,
Munich, Germany) is advanced via the external
carotid artery into the descending aorta. The indica-
tor bolus consists of two components. Indocyanine
green serves as intravascular marker and ice cold 5%
glucose as a thermal intra- and extravascular indica-
tor. The bolus is injected via the external jugular
artery with a temperature controlled injector. The di-
lution curves for dye and temperature are recorded
simultaneously in the descending aorta with the ther-
mistor tipped fiberoptic catheter. Thoracic intravascu-
lar and extravascular fluid volumes are determined
based on the measurement of the mean transit times
for thermal and dye indicators and of the decay time
volumes calculated from the indicator dilution curves
as described previously [3]. The lung water computer
(System Cold Z-021, Pulsion) determines the mean
transit time for the thermal indicator and for the dye
indicator and calculates total thermal volume (ITTV),
intrathoracic blood volume (ITBV), and extravascular
thermal volume (ETV) [4]. ETV, respectively EVLW
are calculated as follows: ETVITTVITBV. All
measurements were made hourly in triplicate. The
mean value was used for analysis.
2.7. Myeloperoxidase assay
Lung samples were frozen immediately and stored
at 70°C until assay. Quantitative MPO activity was
determined as previously described [5]. Frozen lung
tissue (100 mg) was homogenized in 1 ml of 0.5%
hexadecyltrimethylammonium bromide (to release
myeloperoxidase (MPO) from the primary granules of
the PMN), 5 mmol:l EDTA, and 50 mmol:l potas-
sium phosphate buffer (pH 6.2) with a tissue grinder.
The homogenate was centrifuged at 10000g for 15
min at 4°C. The supernatant was assayed for total
soluble protein by the method of Pierce Laboratories
[6] and for MPO activity. Enzyme activity was mea-
sured spectrophotometrically: 10 mg of 5-fold super-
natant was combined with 0.6 ml Hanks’ BSA, 0.5
ml of 100 mmol:l potassium phosphate buffer (pH
6.2), 0.1 ml 0.05% H2O2, and 0.1 ml of 1.25 mg:ml
o-dianisidine. Color development was stopped by
addition of 1% NaN3 after five, respectively, 20 min
at room temperature. The optical density was mea-
sured at 460 nm with a spectrophotometer (Kadas
100, Dr.Lange AG Zu¨rich, Switzerland). Color devel-
opment from 5 to 20 min was linear. Enzyme activity
is expressed as change in optical density unit per mil-
ligram of tissue protein per minute (DOD:mg per
min).
2.8. Thiobarbituric acid reacti6e substances
Lung samples were frozen immediately and stored
at 70°C until assay. TBARS were measured ac-
cording to the method of Ohkawa et al. [7] in 10%
wet weight per volume homogenate. Aliquots (0.2 ml)
of this homogenate were added to tubes containing
0.2 ml of 8.1% sodium dodecyl sulfate, 1.5 ml of 20%
acetic acid solution adjusted to pH 3.5 with NaOH,
and 1.5 ml of 0.8% solution of thiobarbituric acid.
The mixture was brought to a volume of 4 ml by the
addition of distilled water, heated at 95°C for 60 min,
and then cooled with tap water. A volume of 1 ml of
distilled water and 5 ml of butanol:pyridine (15:1,
v:v) were added (all chemicals by Fluka AG, Switzer-
land). The solution was centrifuged at 4000 rpm for
10 min. The absorbance of the upper layer was mea-
sured at 532 nm with a spectrophotometer (Kadas
100). The TBARS levels were determined by reference
to a standard curve of 1,1,3,3-tetramethoxypropane
(Sigma), and the results were expressed as picomoles
of malondialdehyde per gram of wet lung.
2.9. Statistical analysis
All values are given as the mean9standard error
of the mean (S.E.M). Analysis for repeated measures
was performed by ANOVA (Statistica 4.5 StatSoft
1993) and planned comparison was used. Differences
were considered significant at the PB0.05 level.
3. Results
3.1. Characteristics of experimental groups
Donor weight was 28.190.9 kg and recipient
weight 27.692.3 kg in Group I. In Group II the
weights were 28.291.3 and 27.891.3 kg, respec-
tively. There was no statistical difference between
groups.
Preservation time was 1217.6916.5 min in Group
I and 1215.0916.0 min in Group II (difference not
significant). Mean warm ischemia in Group II was
148.297.3 min. Body temperatures of recipients did
not differ in both groups (35.390.26 in Group I,
35.290.37oC in Group II).
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3.2. Gas exchange
PaO2 did not differ at baseline (63.996.8 kPa in
Group I and 66.993.1 kPa in Group II). At 1 h after
occlusion of the right lung, the PaO2 dropped to 50.89
13.1 kPa in Group I, whereas in Group II, a higher
PaO2 of 57.797.4 kPa was measured. This difference
was not statistically significant. At 4 h after reperfusion,
the difference in PaO2 was even higher (Group I:
48.7912.4 vs. Group II: 61.497.8 kPa), but not statis-
tically significant.
3.3. Hemodynamic parameters
Cardiac output was lower at the baseline in Group II
(Fig. 1). At 1 h after occlusion of the right lung, CO
was 3.0690.10 l:min in Group I and 3.5690.15 l:min
in Group II (P0.06). This trend to an improved
cardiac output in the group with warm ischemia per-
sisted during the whole observation period, however, no
statistically significant difference was noted.
Mean pulmonary artery pressure was the same in
both groups at baseline. At 1 h after occlusion, a
slightly lower PAPmean in Group II compared to Group
I was observed (32.491.9 vs. 34.091.8 mmHg, P
0.62). At the end of the assessment, the mean PAP was
32.093.0 mmHg in Group I and 29.891.3 mmHg in
Group II (P0.65).
Pulmonary vascular resistance was higher in Group
II at baseline (159.0927.3 vs. 121.8916.8 dyne:s per
cm5, P0.45). At 1 h after occlusion of the con-
tralateral right lung PVR was higher in the group with
topical cooling (603.0944.0 vs. 532.0948.5 dyne:s per
cm5, P0.41) but 4 h after occlusion PVR was lower
in Group I than in Group II (554.59109 vs. 570.99
Fig. 2. EVLWI at baseline and 1, 2, 3 and 4 h after occlusion of the
right contralateral lung (mean9S.E.M.).
62.1 dyne:s per cm5, P0.73). No statistical signifi-
cant difference in pulmonary vascular resistence was
found during the whole observation period.
3.4. Reperfusion edema
After occlusion of the right lung, one hour after
reperfusion, only EVLWI of the graft was measured.
EVLWI at this time point was lower in Group II
(7.7791.57 ml:kg) compared to Group I (10.1290.64
ml:kg, P0.25). This trend to reduced edema (Fig. 2)
in the group without topical cooling persisted until four
hours after occlusion (6.7491.1 vs. 9.2290.90 ml:kg,
P0.23). However, differences were not significant.
Intrathoracic blood volume showed no differences
between the groups.
3.5. PMN migration
A tendency to a reduced MPO-activity in Group II
(3.2590.19 DOD:mg per min), compared to Group I
(4.5290.64 DOD:mg per min), was noted at the end of
the observation period (PB0.08) Fig. 3.
3.6. Lipid peroxidation
No difference of TBARS in tissue homogenates be-
tween groups was seen 5 h after reperfusion: Group I
12.0790.86 pmol:kg compared to Group II 12.079
1.18 pmol:g (Fig. 3).
4. Discussion
Various experiments have been conducted to evaluate
the optimal preservation conditions in lung transplanta-
Fig. 1. Cardiac output at baseline and 1, 2, 3 and 4 h after occlusion
of the right contralateral lung (mean9S.E.M.).
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Fig. 3. MPO-Assay and TBARS in graft tissue at the end of the observation period (mean9S.E.M.).
tion; and the mechanisms of ischemia-reperfusion in-
jury have been studied extensively in the field of tho-
racic organ transplantation. However, to our
knowledge the beneficial effect of topical lung cooling
during implantation with subsequent rapid reperfusion
of the cold organ on posttransplant lung edema and
hemodynamics has not been evaluated.
In the present experiment we compared the effect of
topical cooling during implantation to prewarming of
the organ for a 2-h period at room temperature prior to
reperfusion. Surprisingly we found that prewarming of
the lung allograft and avoidance of topical cooling with
ice slush did not impair post-transplant graft function.
On the contrary, a tendency to improved posttransplant
hemodynamics, reduced reperfusion edema, and re-
duced PMN migration to the allograft was noted. The
beneficial effect on pulmonary vascular resistance was
most marked in the early phase of reperfusion.
Without focusing directly on the problem of rewarm-
ing a number of previously performed studies by other
groups support our finding that low temperature of the
organ at the time of reperfusion might enhance the
development of reperfusion injury and vascular dys-
function. Moriyasu et al. [8] studied the effect of an
initial warm (20°C) crystalloid flush before regular
reperfusion after a 6-h preservation period in an ex vivo
rabbit model. The flush was used to eliminate toxic
metabolites from the vascular system. The observed
improvement of pulmonary vascular resistance after
reperfusion might be as well a consequence of rewarm-
ing of the graft before reperfusion. Bhabra et al.
demonstrated in a rat lung transplant model that initial
low-pressure reperfusion for 10 min reduces posttrans-
plant lung edema [9]. Also in this experiment it is
possible that the amelioration of reperfusion injury is at
least partially due to a rewarming effect before
reperfusion.
Van Raemdonk et al. demonstrated that lung flush is
the most effective way to change the temperature of the
graft [10]. Reperfusion of the organ with blood at body
temperature, therefore, induces a rapid increase of the
tissue temperature in the graft which might disturb
reorganisation of the cytoskeletal components of the
endothelial cells which demonstrate abnormal configu-
ration already during cold preservation [11]. It was
shown that lungs are able to maintain aerobic
metabolism during storage at 10oC and that this tem-
perature seems to be the ideal storage temperature for
lungs [12,13]. Prewarming activates cell metabolism in a
similar way which might have a beneficial effect on
posttransplant lung injury.
In addition, Ingemansson et al. demonstrated in a
series of experiments that cold preservation severely
impairs endothelial dependent and endothelial indepen-
dent vascular relaxation after reperfusion [14] and that
cold ischemia and reperfusion independently induce
vascular dysfunction. Our results indicate that reperfu-
sion with subsequent rapid rewarming of the lung allo-
graft further increases vascular dysfunction. On the
other hand we could not demonstrate that the short
period of warm ischemia before reperfusion enhances
the production of oxygen free radicals substantially as
lipid peroxidation products, assessed by the measure-
ment of tissue-TBARS 5 h after reperfusion, were not
increased in the group without topical cooling. We also
observed a strong tendency towards a reduction of
PMN migration to the allograft which correlates in
many models with the severity of posttransplant lung
injury. This reduction might be caused by reduced
neutrophil sequestration in the lung, due to reduced
sheer forces by improved hemodynamics, and decreased
PMN and endothelial activation.
In addition, reperfusion injury in this new experimen-
tal setting was evaluated by the measurement of ex-
travascular lung water which is an excellent parameter
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to assess minor differences in posttransplant lung
edema [4]. Clinical studies demonstrated that EVLWI
correlates better to the pathological status of the lung
than gas exchange and radiological signs of edema
[15,16]. A 20-h preservation time was chosen because
following this ischemic injury the recipients still tolerate
ligation of the right pulmonary artery which allows to
assess isolated graft function. If a longer preservation
time is used a rapid decrease of allograft gas exchange
is noted and the animals die from right heart failure.
In our hands temperature measurement in the allo-
graft bronchus was unreliable, therefore mimicking the
clinical situation, the preservation temperature in the
ice box, the room temperature and the recipient’s body
temperature were measured and kept constant in all
experiments. Measuring the lung core temperature
would have harmed the graft. So we are not able to
prove the hypothesis that the 2-h period of warm
ischemia led to a remarkable higher core temperature.
However, it was not our intention to show the time
course of lung parenchyma temperatures with topical
cooling versus prewarming but to imitate the clinical
situation in lung transplantation and compare topical
cooling with the use of no topical cooling.
In conclusion this study in a large animal model of
reperfusion injury following unilateral lung transplanta-
tion indicates that topical cooling of the allograft with
ice slush during separation and implantation seems to
be unnecessary. Posttransplant edema and hemody-
namics in the group without topical cooling were at
least as good in this model than in recipients in which
the lung grafts were cooled topically and reperfused at
low tissue temperature.
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Appendix A. Conference discussion
Dr G. Petterson (Copenhagen, Denmark): Very interesting and
possibly somewhat surprising results. I had some concern when we
did bronchial artery revascularization and allowed the mammary
artery to be open during the course of the procedure, early bronchial
artery reperfusion could be harmful. I have the impression that that
was not the case.
Dr D. van Raemdonck (Leu6en, Belguim): I have a few questions.
First, did you measure lung core temperature in the second group
while this allograft was rewarming? The second question, during the
cold preservation of 20 h did you keep the lung inflated, because it’s
well known that warm ischemic tolerance is prolonged during infla-
tion and clinically during implantation you cannot keep the lung
inflated. Finally, what is your advice for us clinical lung transplant
surgeons? Do we need to cool the lung during implantation or not?
Dr U. Stammberger: Firstly, we did not measure temperature in the
lung allograft because it is known, for example, by the work of van
Raemdonck, that measuring temperature in the bronchus is unreliable
since it does not represent tissue temperature, and all other techniques
to measure temperature in the lung would harm the allograft tissue.
In answer to the second question, the lungs were inflated during
storage and were deflated during implantation. To your last question,
our clinical practice in Zurich is that we use some amount of ice slush
in the thoracic cavity but the lung is not embedded in the ice slush.
This experiment has confirmed that we do not have to change this
practice since maximal topical cooling seems not to be superior.
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Dr N.J. Odom (Manchester, UK): Interesting results and in a way
the opposite to what one would have expected. Do you have any
theory as to why the lungs that are allowed to warm up seem to do
better? In relation to that, may I ask, was there any dextrose in your
preservation solution? It has been shown that lungs stored at 10°C, if
there is a metabolic substrate present, perhaps they do better, and
might that be a possible explanation? But I don’t know if you had
dextrose in your preservation solution or not. Where do you go from
here? How might you explain this? What do you think might be going
on?
Dr U. Stammberger: We use Perfadex as the flush solution and we
also have similar hypotheses on the mechanism during rewarming.
Maybe the short period of warm ischemia allows the endothelial cells
to establish metabolism to a level that let them better cope with
reperfusion injury, but in the presented experiment we did not study
these mechanisms.
D.R. Metras (Marseille, France): I want to congratulate Dr Stamm-
berger for an extremely elegant study and very strange results. The
only thing which is of concern to me is the temperature of your cold
perfusate. It looks like it’s 1°C and topical ice slush. It looks
extremely cold to me, and I thought that too cold was not that good
for the preservation of tissues (this has been shown for the heart). I
want to know why you chose so low a temperature?
Dr U. Stammberger: It is well known that the ideal temperature for
lung preservation is around 10°C. However, in clinical practice the
organ is harvested and stored in a cooling box with a mixture of ice
and water. So, we choose the same temperature as in clinical practice.
We might have seen other results if we choose 10°C storage tempera-
ture.
A. Haverich (Hanno6er, Germany): Now, in clinical practice the
true consequences of reperfusion injury are usually seen after 12–16
h. Your observation period was only 4 h. Would you expect that with
a longer observation period the results might have been different?
Dr U. Stammberger: Extravascular lung water is a very early
parameter of reperfusion injury. So, in our opinion, the 5-h period (1
h reperfusion, then occlusion of the contralateral lung, 4 h assess-
ment) is sufficient. Moreover, at the end of this period, extravascular
lung water was again decreasing in this model. We cannot predict
what the situation might have been after 12 or 16 h. In clinical use
ischemic times up to 6 or 7 h are accepted. After this shorter ischemic
period the consequences of reperfusion injury might be delayed.
.
